{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T22:29:49Z","timestamp":1785796189711,"version":"3.56.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002628","name":"Incheon National University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002628","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.ejphar.2018.08.005","type":"journal-article","created":{"date-parts":[[2018,8,7]],"date-time":"2018-08-07T22:26:20Z","timestamp":1533680780000},"page":"169-178","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["A novel highly potent and selective 11\u03b2-hydroxysteroid dehydrogenase type 1 inhibitor, INU-101"],"prefix":"10.1016","volume":"835","author":[{"given":"Sung Pyo","family":"Hong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongoh","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki-Ho","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soon Kil","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2018.08.005_bib1","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1007\/s00125-002-0959-6","article-title":"Selective inhibition of 11\u03b2-hydroxysteroid dehydrogenase type 1 decreases blood glucose concentrations in hyperglycaemic mice","volume":"45","author":"Alberts","year":"2002","journal-title":"Diabetologia"},{"key":"10.1016\/j.ejphar.2018.08.005_bib2","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1055\/s-2005-870228","article-title":"Effect of high-fat diet on KKAy and ob\/ob mouse liver and adipose tissue corticosterone and 11-dehydrocorticosterone concentrations","volume":"37","author":"Alberts","year":"2005","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.ejphar.2018.08.005_bib3","doi-asserted-by":"crossref","DOI":"10.1210\/en.2003-0344","article-title":"Selective inhibition of 11\u03b2-hydroxysteroid dehydrogenase type 1 improves hepatic insulin sensitivity in hyperglycemic mice strains","volume":"144","author":"Alberts","year":"2003","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejphar.2018.08.005_bib4","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1042\/cs0960513","article-title":"Glucocorticoids and insulin resistance: old hormones, new targets","volume":"96","author":"Andrews","year":"1999","journal-title":"Clin. Sci."},{"key":"10.1016\/j.ejphar.2018.08.005_bib5","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/S0899-9007(00)00422-6","article-title":"Obesity and cortisol","volume":"16","author":"Bj\u00f6rntorp","year":"2000","journal-title":"Nutrition"},{"key":"10.1016\/j.ejphar.2018.08.005_bib6","doi-asserted-by":"crossref","first-page":"740","DOI":"10.2337\/dc12-0354","article-title":"Burden of diabetes on the ability to work","volume":"36","author":"Breton","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ejphar.2018.08.005_bib7","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1152\/physrev.00020.2012","article-title":"11\u03b2-hydroxysteroid dehydrogenases: intracellular gate-keepers of tissue glucocorticoid action","volume":"93","author":"Chapman","year":"2013","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ejphar.2018.08.005_bib8","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1042\/bj20031320","article-title":"Regulation of the enzymes of hepatic microsomal triacylglycerol lipolysis and re-esterification by the glucocorticoid dexamethasone","volume":"378","author":"Dolinsky","year":"2004","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejphar.2018.08.005_bib9","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.1463-1326.2011.01375.x","article-title":"Effects of an 11\u03b2\u2010hydroxysteroid dehydrogenase type 1 inhibitor, MK\u20100916, in patients with type 2 diabetes mellitus and metabolic syndrome","volume":"13","author":"Feig","year":"2011","journal-title":"Diabetes, Obes. Metab."},{"key":"10.1016\/j.ejphar.2018.08.005_bib10","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.tem.2010.06.004","article-title":"Will treating diabetes with 11\u03b2-HSD1 inhibitors affect the HPA axis?","volume":"21","author":"Harno","year":"2010","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.ejphar.2018.08.005_bib11","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1084\/jem.20050119","article-title":"11\u03b2-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in mice","volume":"202","author":"Hermanowski-Vosatka","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ejphar.2018.08.005_bib12","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.1016\/j.bmcl.2015.06.099","article-title":"Discovery of 11\u03b2-hydroxysteroid dehydrogenase type 1 inhibitor","volume":"25","author":"Hong","year":"2015","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejphar.2018.08.005_bib13","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.2337\/diabetes.54.4.1023","article-title":"Adipocyte-specific glucocorticoid inactivation protects against diet-induced obesity","volume":"54","author":"Kershaw","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2018.08.005_bib14","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1210\/en.2012-1019","article-title":"Lack of significant metabolic abnormalities in mice with liver-specific disruption of 11\u03b2-hydroxysteroid dehydrogenase type 1","volume":"153","author":"Lavery","year":"2012","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejphar.2018.08.005_bib15","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1126\/science.1066285","article-title":"A transgenic model of visceral obesity and the metabolic syndrome","volume":"294","author":"Masuzaki","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2018.08.005_bib16","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.mce.2009.09.024","article-title":"Obesity and corticosteroids: 11\u03b2-hydroxysteroid type 1 as a cause and therapeutic target in metabolic disease","volume":"316","author":"Morton","year":"2010","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.ejphar.2018.08.005_bib17","doi-asserted-by":"crossref","first-page":"41293","DOI":"10.1074\/jbc.M103676200","article-title":"Improved lipid and lipoprotein profile, hepatic insulin sensitivity, and glucose tolerance in 11\u03b2-hydroxysteroid dehydrogenase type 1 null mice","volume":"276","author":"Morton","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2018.08.005_bib18","doi-asserted-by":"crossref","first-page":"931","DOI":"10.2337\/diabetes.53.4.931","article-title":"Novel adipose tissue\u2013mediated resistance to diet-induced visceral obesity in 11\u03b2-hydroxysteroid dehydrogenase type 1\u2013deficient mice","volume":"53","author":"Morton","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2018.08.005_bib19","doi-asserted-by":"crossref","first-page":"7088","DOI":"10.1073\/pnas.0305524101","article-title":"Metabolic syndrome without obesity: hepatic overexpression of 11\u03b2-hydroxysteroid dehydrogenase type 1 in transgenic mice","volume":"101","author":"Paterson","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejphar.2018.08.005_bib20","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1111\/j.1463-1326.2012.01582.x","article-title":"11\u03b2\u2010Hydroxysteroid dehydrogenase type 1: relevance of its modulation in the pathophysiology of obesity, the metabolic syndrome and type 2 diabetes mellitus","volume":"14","author":"Pereira","year":"2012","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.ejphar.2018.08.005_bib21","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.2337\/dc09-2315","article-title":"The 11-\u03b2-hydroxysteroid dehydrogenase type 1 inhibitor INCB13739 improves hyperglycemia in patients with type 2 diabetes inadequately controlled by metformin monotherapy","volume":"33","author":"Rosenstock","year":"2010","journal-title":"Diabetes care"},{"key":"10.1016\/j.ejphar.2018.08.005_bib22","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1210\/endo.142.4.8114","article-title":"Minireview: 11\u03b2-hydroxysteroid dehydrogenase type 1\u2014a tissue-specific amplifier of glucocorticoid action","volume":"142","author":"Seckl","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejphar.2018.08.005_bib23","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1515\/hmbci-2013-0015","article-title":"The role and regulation of 11\u03b2-hydroxysteroid dehydrogenase type 1 in obesity and the metabolic syndrome","volume":"15","author":"Stimson","year":"2013","journal-title":"Horm. Mol. Biol. Clin. Investig."},{"key":"10.1016\/j.ejphar.2018.08.005_bib24","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.drudis.2007.06.001","article-title":"Inhibition of 11\u00df-hydroxysteroid dehydrogenase type 1 as a promising therapeutic target","volume":"12","author":"Wamil","year":"2007","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejphar.2018.08.005_bib25","doi-asserted-by":"crossref","first-page":"7048","DOI":"10.1021\/jo200958a","article-title":"Synthesis of potent and orally efficacious 11beta-hydroxysteroid dehydrogenase type 1 inhibitor HSD-016","volume":"76","author":"Wan","year":"2011","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejphar.2018.08.005_bib26","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1743-7075-2-3","article-title":"The role of glucocorticoid action in the pathophysiology of the metabolic syndrome","volume":"2","author":"Wang","year":"2005","journal-title":"Nutr. Metab."},{"key":"10.1016\/j.ejphar.2018.08.005_bib27","article-title":"Discovery of BI 135585, an in vivo efficacious oxazinanone-based 11\u03b2 hydroxysteroid dehydrogenase type 1 inhibitor","author":"Zhuang","year":"2017","journal-title":"Bioorg. Med. Chem."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299918304503?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299918304503?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T22:25:47Z","timestamp":1757975147000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299918304503"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":27,"alternative-id":["S0014299918304503"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2018.08.005","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel highly potent and selective 11\u03b2-hydroxysteroid dehydrogenase type 1 inhibitor, INU-101","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2018.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}